Medical News

RSS

Additional data from ChemoCentryx' study of Traficet-EN in Crohn's disease patients

In addition to data released in late November, ChemoCentryx, Inc., announced today more data from the Company's PROTECT-1 (the Prospective Randomized Oral Therapy Evaluation in Crohn's disease Trial) of Traficet-EN(TM) (CCX282-B) in patients with moderate-to-severe Crohn's disease.

8 Dec 2009

Scientists attribute breast cancer decline to publicity surrounding WHI results

Between 2002 and 2003, American women experienced a 7 percent decline in breast cancer incidence, which scientists attribute to the publicity surrounding results of the Women's Health Initiative (WHI).

8 Dec 2009

JAK2 inhibitor can control myelofibrosis, report researchers

A first-in-its class oral medication provides significant and durable relief for patients with a rare, debilitating and lethal bone marrow disorder called myelofibrosis, researchers at The University of Texas M. D. Anderson Cancer Center reported today at the 51st Annual Meeting of the American Society of Hematology.

8 Dec 2009

Roche Diagnostics launches new customer training center in Pleasanton, California

Roche Diagnostics announced today the opening of a new west-coast customer training center in Pleasanton, California, as part of an initiative to make state-of-the-art training on diagnostic equipment more accessible to hospitals and independent laboratories on the west and east coasts.

From Roche Sequencing and Life Science 8 Dec 2009

Turmeric and pepper may play a role in preventing breast cancer

A new study finds that compounds derived from the spices turmeric and pepper could help prevent breast cancer by limiting the growth of stem cells, the small number of cells that fuel a tumor's growth.

8 Dec 2009

New data from NanoBio's nanoemulsion-based adjuvant platform to be presented

NanoBio Corporation announced today that its CEO and Founder, James R. Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza Congress, taking place from December 7-9, 2009 in Brussels, Belgium.

8 Dec 2009

Sectra achieves increased operating profit for the first half of fiscal year

IT and medical-technology company Sectra’s (STO:SECTB) net sales for the first half of the fiscal year increased 4.9% to SEK 391.7 million (373.4) compared with the year-earlier period. Operating profit rose 87.5% to SEK 16.5 million (8.8), corresponding to an operating margin of 4.2% (2.4). Profit after net financial items amounted to SEK 4.4 million (48.2), corresponding to a profit margin of 1.1% (12.9).

8 Dec 2009

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

The SAVI™ applicator for breast brachytherapy is a safe, effective therapy for breast cancer, according to a newly published study in a peer-reviewed journal.

8 Dec 2009

Defibrotide drug effective against hepatic veno-occlusive disease

Defibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more effective than standard treatment in post-stem cell transplant patients with hepatic veno-occlusive disease, a life threatening toxicity of transplant caused by blockages in tiny blood vessels of the liver, according to a study led by Dana-Farber Cancer Institute scientists.

8 Dec 2009

Novo Nordisk in-licenses intellectual property rights to IL-21 antibodies

Novo Nordisk A/S and ZymoGenetics, Inc. today announced an agreement where Novo Nordisk in-licenses a fully-human anti-IL21 monoclonal antibody (IL-21 mAb) developed by ZymoGenetics, as well as broad intellectual property rights covering IL-21 mAb and the development of other IL-21 antibodies.

From Novo Nordisk 8 Dec 2009

Canadians’ health and well-being can be improved by adopting certain environmental health measures

The health and well-being of Canadians could be greatly improved by adopting some of the environmental health approaches taken in Australia, Sweden and California, according to a Conference Board of Canada report, Critical Steps for Canada: Environmental Health Lessons Across Borders.

8 Dec 2009

Geisinger installs catheter-based cardiac assist device, Impella 2.5

A minimally invasive, catheter-based cardiac assist device - the Impella 2.5 - is credited with saving the life of 86-year-old Rose Lombardo of Hazleton. Grandmother to seven and great-grandmother to another 12, Rose was "at death's door" after suffering concurrent heart attacks, according to her daughter, Gabriella Norgard.

8 Dec 2009

H1N1 virus produces pulmonary damage similar to earlier flu pandemics

In fatal cases of 2009 H1N1 influenza, the virus can damage cells throughout the respiratory airway, much like the viruses that caused the 1918 and 1957 influenza pandemics, report researchers from the National Institutes of Health (NIH) and the New York City Office of Chief Medical Examiner.

8 Dec 2009

'Hand Hygiene Saves Lives' encourages patients to remind healthcare staff to wash their hands

The Centers for Disease Control and Prevention (CDC), Catholic Healthcare Partners (CHP) and the Premier healthcare alliance today released research showing that a video can be an effective tool for encouraging patients to remind healthcare staff to wash their hands.

8 Dec 2009

Study shows middle-aged parents are more involved in their grown children's lives than ever

Middle-aged parents are more involved in their grown children's lives than ever, according to new research from Purdue University.

8 Dec 2009

Long-chain omega-3 fatty acids can prevent colorectal cancer

Long-chain omega-3 fatty acids, primarily found in fish and seafood, may have a role in colorectal cancer prevention, according to results presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held Dec. 6-9, 2009, in Houston.

8 Dec 2009

Exercise can reduce overall mortality rates in patients with prostate cancer, according to findings

As little as 15 minutes of exercise a day can reduce overall mortality rates in patients with prostate cancer, according to findings presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference, held here, Dec. 6-9, 2009.

8 Dec 2009

Myriant Technologies receives $50 million for biobased Succinic Acid facility in Louisiana

Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana.

8 Dec 2009

Human blood stem cells can be engineered to kill HIV-infected cells, find researchers

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases.

8 Dec 2009

Potentially promising data from Phase I/II study of elotuzumab presented at ASH 2009

Facet Biotech Corporation and Bristol-Myers Squibb Company announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented today at the American Society of Hematology (ASH) 2009 Annual Meeting in New Orleans.

8 Dec 2009

Medical News

Additional data from ChemoCentryx' study of Traficet-EN in Crohn's disease patients

Scientists attribute breast cancer decline to publicity surrounding WHI results

JAK2 inhibitor can control myelofibrosis, report researchers

Roche Diagnostics launches new customer training center in Pleasanton, California

Turmeric and pepper may play a role in preventing breast cancer

New data from NanoBio's nanoemulsion-based adjuvant platform to be presented

Sectra achieves increased operating profit for the first half of fiscal year

SAVI applicator for breast brachytherapy can be an effective therapy for breast cancer

Defibrotide drug effective against hepatic veno-occlusive disease

Novo Nordisk in-licenses intellectual property rights to IL-21 antibodies

Canadians’ health and well-being can be improved by adopting certain environmental health measures

Geisinger installs catheter-based cardiac assist device, Impella 2.5

H1N1 virus produces pulmonary damage similar to earlier flu pandemics

'Hand Hygiene Saves Lives' encourages patients to remind healthcare staff to wash their hands

Study shows middle-aged parents are more involved in their grown children's lives than ever

Long-chain omega-3 fatty acids can prevent colorectal cancer

Exercise can reduce overall mortality rates in patients with prostate cancer, according to findings

Myriant Technologies receives $50 million for biobased Succinic Acid facility in Louisiana

Human blood stem cells can be engineered to kill HIV-infected cells, find researchers

Potentially promising data from Phase I/II study of elotuzumab presented at ASH 2009

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News